387 related articles for article (PubMed ID: 26373710)
1. The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study.
Kato G; Shimizu Y; Arai Y; Suzuki N; Sugamori Y; Maeda M; Takahashi M; Tamura Y; Wakabayashi N; Murali R; Ono T; Ohya K; Mise-Omata S; Aoki K
Arthritis Res Ther; 2015 Sep; 17(1):251. PubMed ID: 26373710
[TBL] [Abstract][Full Text] [Related]
2. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
[TBL] [Abstract][Full Text] [Related]
3. Total Saponin from Anemone flaccida Fr. Schmidt Prevents Bone Destruction in Experimental Rheumatoid Arthritis via Inhibiting Osteoclastogenesis.
Liu C; Yang Y; Sun D; Wang C; Wang H; Jia S; Liu L; Lin N
Rejuvenation Res; 2015 Dec; 18(6):528-42. PubMed ID: 26418168
[TBL] [Abstract][Full Text] [Related]
4. RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines.
Naidu VG; Dinesh Babu KR; Thwin MM; Satish RL; Kumar PV; Gopalakrishnakone P
Chem Biol Interact; 2013 Apr; 203(2):467-79. PubMed ID: 23333834
[TBL] [Abstract][Full Text] [Related]
5. The intra-articular injection of RANKL-binding peptides inhibits cartilage degeneration in a murine model of osteoarthritis.
Haque Bhuyan MZ; Tamura Y; Sone E; Yoshinari Y; Maeda C; Takahashi M; Tabata Y; Murali R; Waki Y; Aoki K
J Pharmacol Sci; 2017 Jun; 134(2):124-130. PubMed ID: 28648299
[TBL] [Abstract][Full Text] [Related]
6. Boldine isolated from Litsea cubeba inhibits bone resorption by suppressing the osteoclast differentiation in collagen-induced arthritis.
Zhao H; Xu H; Qiao S; Lu C; Wang G; Liu M; Guo B; Tan Y; Ju D; Xiao C
Int Immunopharmacol; 2017 Oct; 51():114-123. PubMed ID: 28826044
[TBL] [Abstract][Full Text] [Related]
7. Fengshi Qutong capsule ameliorates bone destruction of experimental rheumatoid arthritis by inhibiting osteoclastogenesis.
Li Y; Yang C; Jia K; Wang J; Wang J; Ming R; Xu T; Su X; Jing Y; Miao Y; Liu C; Lin N
J Ethnopharmacol; 2022 Jan; 282():114602. PubMed ID: 34492323
[TBL] [Abstract][Full Text] [Related]
8. RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.
Stolina M; Schett G; Dwyer D; Vonderfecht S; Middleton S; Duryea D; Pacheco E; Van G; Bolon B; Feige U; Zack D; Kostenuik P
Arthritis Res Ther; 2009; 11(6):R187. PubMed ID: 20003323
[TBL] [Abstract][Full Text] [Related]
9. miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin.
Chen Y; Wang X; Yang M; Ruan W; Wei W; Gu D; Wang J; Guo X; Guo L; Yuan Y
Med Sci Monit; 2018 Jul; 24():5292-5300. PubMed ID: 30059491
[TBL] [Abstract][Full Text] [Related]
10. Asperosaponin VI protects against bone destructions in collagen induced arthritis by inhibiting osteoclastogenesis.
Liu K; Liu Y; Xu Y; Nandakumar KS; Tan H; He C; Dang W; Lin J; Zhou C
Phytomedicine; 2019 Oct; 63():153006. PubMed ID: 31299594
[TBL] [Abstract][Full Text] [Related]
11. RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis.
Martínez-Calatrava MJ; Prieto-Potín I; Roman-Blas JA; Tardio L; Largo R; Herrero-Beaumont G
Arthritis Res Ther; 2012 Jun; 14(3):R149. PubMed ID: 22709525
[TBL] [Abstract][Full Text] [Related]
12. Delivery of RANKL-Binding Peptide OP3-4 Promotes BMP-2-Induced Maxillary Bone Regeneration.
Uehara T; Mise-Omata S; Matsui M; Tabata Y; Murali R; Miyashin M; Aoki K
J Dent Res; 2016 Jun; 95(6):665-72. PubMed ID: 27006466
[TBL] [Abstract][Full Text] [Related]
13. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.
Saidenberg-Kermanac'h N; Corrado A; Lemeiter D; deVernejoul MC; Boissier MC; Cohen-Solal ME
Bone; 2004 Nov; 35(5):1200-7. PubMed ID: 15542046
[TBL] [Abstract][Full Text] [Related]
14. Is RANKL inhibition both anti-resorptive and anabolic in rheumatoid arthritis?
Sims NA; Romas E
Arthritis Res Ther; 2015 Nov; 17():328. PubMed ID: 26577945
[TBL] [Abstract][Full Text] [Related]
15. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous injections of a TNF-alpha antagonistic peptide inhibit both inflammation and bone resorption in collagen-induced murine arthritis.
Kojima T; Aoki K; Nonaka K; Saito H; Azuma M; Iwai H; Varghese BJ; Yoshimasu H; Baron R; Ohya K; Amagasa T
J Med Dent Sci; 2005 Mar; 52(1):91-9. PubMed ID: 15868746
[TBL] [Abstract][Full Text] [Related]
17. RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation.
Danks L; Komatsu N; Guerrini MM; Sawa S; Armaka M; Kollias G; Nakashima T; Takayanagi H
Ann Rheum Dis; 2016 Jun; 75(6):1187-95. PubMed ID: 26025971
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis.
Romas E; Sims NA; Hards DK; Lindsay M; Quinn JW; Ryan PF; Dunstan CR; Martin TJ; Gillespie MT
Am J Pathol; 2002 Oct; 161(4):1419-27. PubMed ID: 12368214
[TBL] [Abstract][Full Text] [Related]
19. Minodronic acid influences receptor activator of nuclear factor kappaB ligand expression and suppresses bone resorption by osteoclasts in rats with collagen-induced arthritis.
Tanishima S; Kishimoto Y; Fukata S; Mizumura H; Hagino H; Teshima R
Mod Rheumatol; 2007; 17(3):198-205. PubMed ID: 17564774
[TBL] [Abstract][Full Text] [Related]
20. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
